Compound E, chemically designated as 209986-17-4, represents a significant exploration within the field of Alzheimer's condition research. This γ-secretase modulator was initially developed as a potential https://fannienigi956728.mpeblog.com/73239845/γ-secretase-suppressor-compound-e-209986-17-4